September 25, 2016 8:23 AM ET

Biotechnology

Company Overview of Rigel Pharmaceuticals, Inc.

Executive Profile

Gary A. Lyons

Chairman, Member of Compensation Committee and Member of Finance Committee, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 10 different industries.

See Board Relationships
56$268,650

Background

Mr. Gary A. Lyons served as the President and Chief Executive Officer of Neurocrine Biosciences, Inc. from February 1993 to January 2008. From 1983 to 1993, Mr. Lyons held various executive positions at Genentech Inc., including Vice President of Business Development, Vice President of Sales and Director of Sales & Marketing. He has over 35 years of management experience in the biotechnology and pharmaceutical industries. He served as a Director of Sales at American ...

Corporate Headquarters

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships

1993-Present
Independent Director and Member of Technology & Medical Sciences Committee
1997-Present
Director, Chairman of Nominating/Governance Committee and Member of Compensation Committee
2005-Present
Chairman, Member of Compensation Committee and Member of Finance Committee
2013-Present
Independent Director, Chairman of Compensation Committee, Member of Governance & Nominating Committee and Member of Audit Committee
2014-Present
Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education

BS
The University of New Hampshire, Durham
MBA
J.L. Kellogg School of Management, Northwestern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$110,250
Total Calculated Compensation$268,650
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Amit D. Munshi Chief Executive Officer, President and Director
Arena Pharmaceuticals, Inc.
--
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
$575.3K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$919.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science Committee
Progenics Pharmaceuticals, Inc.
$597.1K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rigel Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.